Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
8,23 USD | +7,86 % | +1,60 % | -18,19 % |
26/04 | Cytokinetics nombra a Sung Lee director financiero | MT |
18/04 | Vir Biotechnology, Inc. anuncia el cese de Sung Lee como vicepresidente ejecutivo, con efecto a partir del 3 de mayo de 2024 | CI |
Resumen de negocios
Número de empleados: 587
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Antibody-based Therapies
100,0
%
| 1 616 | 100,0 % | 86 | 100,0 % | -94,67 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 616 | 100,0 % | 86 | 100,0 % | -94,67 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 56 | - | |
Sung Lee
DFI | Director of Finance/CFO | 53 | 27/03/23 |
Jennifer Towne
CTO | Chief Tech/Sci/R&D Officer | - | 06/11 |
Aine M. Hanly
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/03/21 |
George Scangos
BRD | Director/Board Member | 76 | 01/01/17 |
Richard Lepke
IRC | Investor Relations Contact | - | 01/01 |
Sasha Ellis
PRN | Corporate Officer/Principal | - | 10/07/23 |
Lynne Krummen
PRN | Corporate Officer/Principal | - | 01/01/18 |
Corporate Officer/Principal | 73 | - | |
Jeff Calcagno
PRN | Corporate Officer/Principal | - | 15/05/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Charles Sigal
BRD | Director/Board Member | 72 | 02/07/20 |
Robert Perez
BRD | Director/Board Member | 59 | 01/01/17 |
Robert More
BRD | Director/Board Member | 56 | 01/09/16 |
Phillip Sharp
BRD | Director/Board Member | 79 | 01/01/17 |
Robert Nelsen
FOU | Founder | 60 | 07/04/16 |
Vicki Sato
CHM | Chairman | 75 | 01/12/16 |
George Scangos
BRD | Director/Board Member | 76 | 01/01/17 |
Director/Board Member | 48 | 01/09/19 | |
Janet Napolitano
BRD | Director/Board Member | 65 | 28/08/20 |
Chief Executive Officer | 56 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 135 843 977 | 116 627 968 ( 85,85 %) | 0 | 85,85 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-18,19 % | 1036,49 M | |
+1,51 % | 42,59 mil M | |
+8,57 % | 40,65 mil M | |
+49,22 % | 40,57 mil M | |
-12,36 % | 26,77 mil M | |
+8,92 % | 24,81 mil M | |
-25,13 % | 18,17 mil M | |
+29,17 % | 12,05 mil M | |
-3,12 % | 11,7 mil M | |
+6,35 % | 11,1 mil M |
- Bolsa de valores
- Acciones
- Acción VIR
- Empresa Vir Biotechnology, Inc.